Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ GALT Recombinant Rabbit Monoclonal Antibody (19E1)

Rabbit Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA550064

Catalog No. FEMA550064


Only null left
Add to Cart

Description

Description

GALT Recombinant Monoclonal Antibody for Flow, ELISA

Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

GALT
Recombinant Monoclonal
0.2 mg/mL
PBS with 0.05% BSA, 50% glycerol and 0.02% sodium azide; pH 7.4
P07902
Galt
A synthesized peptide derived from human GALT.
100 μL
Primary
Human
Antibody
IgG
ELISA, Flow Cytometry
19E1
Unconjugated
Galt
AW553376; Gal-1-P uridylyltransferase; galactose-1-phosphate uridyl transferase; galactose-1-phosphate uridylyltransferase; galactose-1-phosphate uridylyltransferase isoform 1; GALT; IL11RA; interleukin 11 receptor, alpha; UDP-glucose--hexose-1-phosphate uridylyltransferase
Rabbit
Affinity Chromatography
RUO
2592
-20°C or -80°C if preferred
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.